Severe or therapy-resistant asthma is increasingly recognised as a major unmet need. A
Task Force, supported by the European Respiratory Society and American Thoracic Society, …

Background. In atopic asthma, activated T helper lymphocytes are present in bronchial-biopsy
specimens and bronchoalveolar-lavage (BAL) fluid, and their production of cytokines may …

Atopic dermatitis is a chronic inflammatory skin disease associated with cutaneous hyperreactivity
to environmental triggers and is often the first step in the atopic march that results in …

Background: IL-17 is a cytokine that has been reported to be produced by T lymphocytes. In
vitro, IL-17 activates fibro-blasts and macrophages for the secretion of GM-CSF, TNF-α, IL-1β…

There are remarkable differences in the diagnostic and therapeutic management of atopic
dermatitis practiced by dermatologists and pediatricians in different countries. Therefore, the …

Background: Microbial superantigens have been described to contribute to the pathogenesis
of chronic inflammatory diseases often complicated by insensitivity to glucocorticoid therapy…

The histopathology of bronchial asthma is associated with structural changes within the
airways, including subepithelial fibrosis, as well as chronic eosinophilic inflammation. The …

Background Some studies of severe asthma suggest that persistence or alteration in the
pattern of inflammation may be associated with the severity of the disease. Whether there are …

Nitric oxide (NO) is a mediator of vasodilatation and bronchodilatation synthesised from L-arginine
by the enzyme NO synthase, which is either constitutive or induced by …

Background Pollen immunotherapy is effective in selected patients with IgE-mediated
seasonal allergic rhinitis, although it is questionable whether there is long-term benefit after the …